Since a reduction in GLUT2 expression has been related to reduced hepatic glucose efflux in several conditions, such as the Fanconi-Bickel syndrome [41] and the Foxa3-/- mice [42], this result points out the hepatic territory as responsible for the beneficial effects of resveratrol. Here, FOXA3 is linked to glycogen storage disease due to GLUT2 deficiency.